SER:NYSEMKT, Serina Therapeutics, Inc.

SER stock overview

Serina Therapeutics, Inc. (SER:NYSEMKT) closed at $1.42 on November 16, 2026, up 2.16% on the day. The stock trades 66.7% below its 52-week high of $4.26 and 24.6% above its 52-week low of $1.14. Over the past year, it lost 62.2%. Serina Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$1.42
Day change
+2.16%
Volume
56,667
Average volume
71,910
Market cap
37M+
52-week range
$1.14 – $4.26
50-day average
$1.94
200-day average
$2.02

Price action over the past year

In 252 trading sessions since November 14, 2025, SER closed higher on 105 days (42%). Its best day was March 19, 2026 (+93.75%) and its worst was March 24, 2026 (-22.86%). The stock moved 10% or more in a single session 25 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

SER news

About Serina Therapeutics, Inc.

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.

Similar stocks

Find more stocks like SER with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.